US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 56.740
  • +0.750+1.34%
Trading Aug 8 11:19 ET
10.48BMarket Cap-59726P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
12.41%699.26M
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
Operating revenue
12.41%699.26M
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
Cost of revenue
20.89%189.8M
8.41%170.1M
13.89%654.2M
16.76%171.82M
13.92%168.53M
8.58%157M
16.48%156.9M
25.21%574.4M
23.60%147.16M
27.86%147.94M
Gross profit
9.54%509.46M
4.91%467.42M
22.23%1.85B
17.06%475.07M
22.57%459.81M
23.35%465.09M
26.62%445.55M
15.41%1.51B
14.40%405.84M
10.11%375.14M
Operating expense
-2.57%527.6M
9.00%569.69M
-1.32%2.06B
4.14%542.87M
-10.70%452.96M
2.17%541.52M
-1.18%522.65M
-2.63%2.09B
-9.53%521.28M
5.15%507.25M
Selling and administrative expenses
-6.59%387.2M
7.72%435.5M
2.34%1.62B
1.72%411.03M
2.87%390.55M
4.25%414.5M
0.57%404.3M
-4.80%1.58B
-12.85%404.09M
-0.90%379.67M
-Selling and marketing expense
4.65%51.8M
-4.91%50.4M
-29.57%203.9M
-22.91%57.59M
-33.54%43.86M
-32.01%49.5M
-30.35%53M
-66.41%289.5M
-88.88%74.7M
-0.91%66M
-General and administrative expense
-8.11%335.4M
9.62%385.1M
9.48%1.42B
7.30%353.45M
10.53%346.69M
12.38%365M
7.79%351.3M
61.47%1.29B
258.33%329.39M
-0.89%313.67M
Research and development costs
16.13%120.88M
15.92%110.61M
8.25%425.88M
21.90%114.92M
22.72%111.45M
-1.87%104.1M
-6.68%95.42M
2.02%393.42M
6.54%94.27M
20.51%90.81M
Depreciation amortization depletion
1.67%23.31M
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
-Depreciation and amortization
1.67%23.31M
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
Other operating expenses
---3.8M
--268K
-692.17%-78.43M
---6.4M
-643.85%-72.03M
----
----
--13.24M
--0
--13.24M
Operating profit
76.28%-18.13M
-32.64%-102.26M
62.89%-214.35M
41.27%-67.8M
105.18%6.85M
50.04%-76.43M
56.45%-77.1M
30.87%-577.53M
47.87%-115.44M
6.78%-132.11M
Net non-operating interest income expense
101.42%111K
-293.40%-7.94M
-51.63%-29.77M
-45.38%-7.87M
-50.35%-7.87M
-73.31%-7.82M
202.29%4.11M
-5.53%-19.63M
-16.14%-5.41M
-11.86%-5.24M
Non-operating interest income
----
----
----
----
----
----
--4.11M
----
----
----
Non-operating interest expense
----
--7.94M
75.60%24.42M
64.76%6.54M
72.57%6.54M
----
----
7.98%13.91M
23.39%3.97M
17.15%3.79M
Total other finance cost
-101.42%-111K
----
-6.58%5.35M
-7.90%1.33M
-7.96%1.33M
--7.82M
----
0.00%5.73M
0.00%1.44M
0.00%1.44M
Other net income (expense)
-14.66%3.65M
319.71%1.77M
219.84%42.42M
379.36%25.33M
114.21%2.07M
141.47%4.28M
128.31%421K
-405.96%-35.39M
-823.05%-9.07M
40.21%-14.53M
Gain on sale of security
144.43%11.8M
1,167.96%6.21M
268.41%32.71M
549.51%25.33M
124.06%2.07M
229.82%4.83M
132.95%490K
-161.13%-19.43M
-549.36%-5.64M
-109.72%-8.58M
Special income (charges)
-1,376.81%-8.15M
-6,343.48%-4.45M
160.76%9.7M
--0
--0
91.62%-552K
---69K
20.98%-15.97M
---3.43M
70.58%-5.95M
-Less:Impairment of capital assets
1,376.81%8.15M
6,343.48%4.45M
-96.11%621K
--0
--0
-91.62%552K
--69K
-20.98%15.97M
--3.43M
-70.58%5.95M
-Less:Other special charges
----
----
---10.32M
--0
----
----
----
----
----
----
Income before tax
82.05%-14.35M
-49.56%-108.42M
68.11%-201.75M
61.23%-50.38M
100.69%1.04M
52.38%-79.92M
60.38%-72.49M
24.92%-632.57M
42.22%-129.93M
11.08%-151.88M
Income tax
32.16%1.46M
8.99%1.81M
126.51%2.4M
72.04%-610K
107.99%249K
163.22%1.11M
182.23%1.66M
96.33%-9.06M
48.57%-2.18M
19.23%-3.12M
Net income
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
Net income continuous Operations
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
Minority interest income
Net income attributable to the parent company
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
Basic earnings per share
80.00%-0.09
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.52%0.0044
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
Diluted earnings per share
80.00%-0.09
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.51%0.0043
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 12.41%699.26M5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M
Operating revenue 12.41%699.26M5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M
Cost of revenue 20.89%189.8M8.41%170.1M13.89%654.2M16.76%171.82M13.92%168.53M8.58%157M16.48%156.9M25.21%574.4M23.60%147.16M27.86%147.94M
Gross profit 9.54%509.46M4.91%467.42M22.23%1.85B17.06%475.07M22.57%459.81M23.35%465.09M26.62%445.55M15.41%1.51B14.40%405.84M10.11%375.14M
Operating expense -2.57%527.6M9.00%569.69M-1.32%2.06B4.14%542.87M-10.70%452.96M2.17%541.52M-1.18%522.65M-2.63%2.09B-9.53%521.28M5.15%507.25M
Selling and administrative expenses -6.59%387.2M7.72%435.5M2.34%1.62B1.72%411.03M2.87%390.55M4.25%414.5M0.57%404.3M-4.80%1.58B-12.85%404.09M-0.90%379.67M
-Selling and marketing expense 4.65%51.8M-4.91%50.4M-29.57%203.9M-22.91%57.59M-33.54%43.86M-32.01%49.5M-30.35%53M-66.41%289.5M-88.88%74.7M-0.91%66M
-General and administrative expense -8.11%335.4M9.62%385.1M9.48%1.42B7.30%353.45M10.53%346.69M12.38%365M7.79%351.3M61.47%1.29B258.33%329.39M-0.89%313.67M
Research and development costs 16.13%120.88M15.92%110.61M8.25%425.88M21.90%114.92M22.72%111.45M-1.87%104.1M-6.68%95.42M2.02%393.42M6.54%94.27M20.51%90.81M
Depreciation amortization depletion 1.67%23.31M1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M
-Depreciation and amortization 1.67%23.31M1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M
Other operating expenses ---3.8M--268K-692.17%-78.43M---6.4M-643.85%-72.03M----------13.24M--0--13.24M
Operating profit 76.28%-18.13M-32.64%-102.26M62.89%-214.35M41.27%-67.8M105.18%6.85M50.04%-76.43M56.45%-77.1M30.87%-577.53M47.87%-115.44M6.78%-132.11M
Net non-operating interest income expense 101.42%111K-293.40%-7.94M-51.63%-29.77M-45.38%-7.87M-50.35%-7.87M-73.31%-7.82M202.29%4.11M-5.53%-19.63M-16.14%-5.41M-11.86%-5.24M
Non-operating interest income --------------------------4.11M------------
Non-operating interest expense ------7.94M75.60%24.42M64.76%6.54M72.57%6.54M--------7.98%13.91M23.39%3.97M17.15%3.79M
Total other finance cost -101.42%-111K-----6.58%5.35M-7.90%1.33M-7.96%1.33M--7.82M----0.00%5.73M0.00%1.44M0.00%1.44M
Other net income (expense) -14.66%3.65M319.71%1.77M219.84%42.42M379.36%25.33M114.21%2.07M141.47%4.28M128.31%421K-405.96%-35.39M-823.05%-9.07M40.21%-14.53M
Gain on sale of security 144.43%11.8M1,167.96%6.21M268.41%32.71M549.51%25.33M124.06%2.07M229.82%4.83M132.95%490K-161.13%-19.43M-549.36%-5.64M-109.72%-8.58M
Special income (charges) -1,376.81%-8.15M-6,343.48%-4.45M160.76%9.7M--0--091.62%-552K---69K20.98%-15.97M---3.43M70.58%-5.95M
-Less:Impairment of capital assets 1,376.81%8.15M6,343.48%4.45M-96.11%621K--0--0-91.62%552K--69K-20.98%15.97M--3.43M-70.58%5.95M
-Less:Other special charges -----------10.32M--0------------------------
Income before tax 82.05%-14.35M-49.56%-108.42M68.11%-201.75M61.23%-50.38M100.69%1.04M52.38%-79.92M60.38%-72.49M24.92%-632.57M42.22%-129.93M11.08%-151.88M
Income tax 32.16%1.46M8.99%1.81M126.51%2.4M72.04%-610K107.99%249K163.22%1.11M182.23%1.66M96.33%-9.06M48.57%-2.18M19.23%-3.12M
Net income 80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M
Net income continuous Operations 80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M
Minority interest income
Net income attributable to the parent company 80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M
Basic earnings per share 80.00%-0.09-42.86%-0.668.08%-1.1362.50%-0.27100.52%0.004452.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.84
Diluted earnings per share 80.00%-0.09-42.86%-0.668.08%-1.1362.50%-0.27100.51%0.004352.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Cancer Research
Cancer Research
Intraday+0.24%